Net Assets for Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's latest reported net assets is $8.65B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
MRNA
Currently viewingNet AssetsSwitch metric
Latest period
$8.65B
YoY change
-20.6%
5Y CAGR
+27.6%
Peak year (2022)
$19.12B
Latest annual
$8.65B
Net Assets history chart for Moderna (MRNA) from 2016 to 2025
Net Assets history table for Moderna (MRNA) from 2016 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $8.65B | -20.6% | ||
| 2024 | $10.90B | -21.3% | ||
| 2023 | $13.85B | -27.6% | ||
| 2022 | $19.12B | +35.2% | ||
| 2021 | $14.14B | +452.3% | ||
| 2020 | $2.56B | +118.0% | ||
| 2019 | $1.17B | -23.2% | ||
| 2018 | $1.53B | +144.7% | ||
| 2017 | $625.30M | -25.7% | ||
| 2016 | $841.85M | — |
Net Assets values are taken from Moderna's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, Moderna (MRNA) net assets totalled $8.65B – declined 20.6% year-over-year.
Moderna net assets compound annual growth for the 2020–2025 (5 years) window is +27.6%, with the latest reading among the more recent periods of the dataset.
Between 2022 and 2025, Moderna net assets plunged 54.8%, falling from $19.12B to $8.65B.
Across the available history, net assets reached its high of $19.12B in 2022 and its low of $625.30M in 2017.
Among 8 Healthcare peers, Moderna (MRNA) ranks 8th; the peer median for net assets is $50.64B.
Moderna Net Assets by Year
Moderna Net Assets 2025: $8.65B
Moderna net assets in 2025 was $8.65B, declined 20.6% below 2024.
Moderna Net Assets 2024: $10.90B
Moderna net assets in 2024 was $10.90B, declined 21.3% below 2023.
Moderna Net Assets 2023: $13.85B
Moderna net assets in 2023 was $13.85B, declined 27.6% below 2022.
Moderna Net Assets 2022: $19.12B
Moderna net assets in 2022 was $19.12B, surged 35.2% from 2021. This figure represents the highest annual value in the available history.
Moderna Net Assets 2021: $14.14B
Moderna net assets in 2021 was $14.14B.
See more financial history for Moderna (MRNA).
Sector peers — Net Assets
Companies in the same sector as Moderna, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Eli Lilly and Company (LLY) | $26.54B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is Moderna's net assets?
- Latest reported net assets for Moderna (MRNA) is $8.65B (period ending December 31, 2025).
How has Moderna net assets changed year-over-year?
- Moderna (MRNA) net assets changed -20.6% year-over-year on the latest annual filing.
What is the long-term growth rate of Moderna net assets?
- Moderna (MRNA) net assets compound annual growth rate is +27.6% over the most recent 5 years available.
When did Moderna net assets hit its highest annual value?
- Moderna net assets reached its highest annual value of $19.12B in 2022.
What was Moderna net assets in 2024?
- Moderna (MRNA) net assets in 2024 was $10.90B.
What was Moderna net assets in 2025?
- Moderna (MRNA) net assets in 2025 was $8.65B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MRNA Overview
Company profile, financial tools, and key metrics
MRNA Revenue Counter
Earns $61.61 every second. See per minute, hour, and day.
MRNA Earnings Counter
Loses −$89.49 per second. See per minute, hour, and day.
MRNA Economic Scale
Exceeds Timor-Leste's GDP. Compare with world economies.
MRNA What If Invested
What if you had invested $1,000? See historical returns from any date.
MRNA How It Makes Money
Discover visual breakdown of $1.94B in revenue — where it comes from and where it goes.
MRNA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRNA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRNA Daily Price Character
Explosive · 48.2% historical win rate (green days). Streaks & record days.
MRNA Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.